GSK2190915

CAS No. 936350-00-4

GSK2190915( AM-803 | Fiboflapon | GSK-2190915 )

Catalog No. M16702 CAS No. 936350-00-4

A potent, selective FLAP inhibitor with binding IC50 of 2.6 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 743 Get Quote
100MG 1116 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    GSK2190915
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective FLAP inhibitor with binding IC50 of 2.6 nM.
  • Description
    A potent, selective FLAP inhibitor with binding IC50 of 2.6 nM; inhibits LTB4 synthesis following ionophore challenge in human whole blood with IC50 of 76 nM (5 h incubation); shows good selectivity over CYP3A4, 2C9, and 2D6; exhibits excellent preclinical toxicology, pharmacokinetics and oral bioactivity.Asthma Phase 2 Clinical.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AM-803 | Fiboflapon | GSK-2190915
  • Pathway
    Immunology/Inflammation
  • Target
    FLAP
  • Recptor
    FLAP
  • Research Area
    Inflammation/Immunology
  • Indication
    Asthma

Chemical Information

  • CAS Number
    936350-00-4
  • Formula Weight
    637.8307
  • Molecular Formula
    C38H43N3O4S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CCOC1=NC=C(C=C1)C2=CC=C(C=C2)CN3C4=C(C=C(C=C4)OCC5=NC=C(C=C5)C)C(=C3CC(C)(C)C(=O)O)SC(C)(C)C
  • Chemical Name
    1H-Indole-2-propanoic acid, 3-[(1,1-dimethylethyl)thio]-1-[[4-(6-ethoxy-3-pyridinyl)phenyl]methyl]-α,α-dimethyl-5-[(5-methyl-2-pyridinyl)methoxy]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Stock NS, et al. J Med Chem. 2011 Dec 8;54(23):8013-29. 2. Lorrain DS, et al. Eur J Pharmacol. 2010 Aug 25;640(1-3):211-8. 3. Kent SE, et al. Clin Exp Allergy. 2013 Feb;43(2):177-86.
molnova catalog
related products
  • GSK2190915 sodium

    A potent, selective FLAP inhibitor with binding IC50 of 2.6 nM.

  • MK-591

    A potent, orally active leukotriene biosynthesis inhibitor that acts by inhibiting 5-lipoxygenase activating protein (FLAP) with IC50 of 1.6 nM in a FLAP binding assay.

  • MK-0591

    A potent, specific and orally active 5-Lipoxygenase-activating protein (FLAP) inhibitor with IC50 of 1.6 nM in FLAP binding assay.